SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Saffhill, R.
Right arrow Articles by O'Connor, P.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Saffhill, R.
Right arrow Articles by O'Connor, P.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Promutagenic Alkyl Lesions are Induced in the Tissue DNA of Animals Treated with Isoniazid

R. Saffhill

Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK

S. Fida

Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK

M. Bromley

Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK

P.J. O'Connor

Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, UK

Further studies have been carried out to determine mechanisms for the toxic and carcinogenic properties of isoniazid (INH) in laboratory animals.

1 Single doses of INH (1.1 mg per mouse), which if given continuously to Swiss mice result in a 50% incidence of lung tumours, lead to the formation of ~ 0.5 and~ 0.3 µmol 06-methylguanine per mol/guanine in the DNA of liver and lung, respectively

2 Repeated doses of INH result in a progressive decrease in the levels of 06-methylguanine in lung DNA and relatively constant levels in hepatic DNA. Treatment with equimolar doses of hydrazine result in higher levels of alkylation in the DNA of liver than of lung.

3 Comparable experiments in Wistar rats show that treatment with hydrazine is very much more effective than INH in inducing the alkylation of liver and lung DNA.

4 Immunocytochemical staining of cryostat sections of liver has been used to show that the formation of 06-methylguanine occurs mainly in the nuclei of hepatocytes.

5 These results demonstrate that treatment with INH leads to the alkylation of tissue DNA and suggest that this may arise via a hydrazine intermediate. The implications of the formation of highly promutagenic lesions in tissue DNA for INH induced toxicity and carcinogenicity are discussed.

Human & Experimental Toxicology, Vol. 7, No. 4, 311-317 (1988)
DOI: 10.1177/096032718800700403


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement